Palavras-chave
Depressão
Como Citar
Resumo
O artigo teve objetivou-se realizar uma revisão dos estudos sobre a epidemiologia, fisiopatologia, impacto clínico e tratamento da depressão em pessoas com DM2. Foram observadas altas taxas de comorbidade entre depressão e DM2, com uma relação bidirecional entre as duas condições, explicada por mecanismos biológicos e ambientais. Os fatores associados à maior prevalência de depressão no diabetes foram sexo feminino, menor escolaridade, menor faixa etária, diagnóstico recente do diabetes, baixa atividade física e uso de insulina. Quanto aos impactos da depressão no DM2, observou-se dificuldade de adesão ao tratamento do diabetes, pior controle glicêmico, maior risco de complicações e mortalidade, implicações econômicas e sociais negativas e redução da qualidade de vida.
Referências
International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium: International Diabetes Federation, 2021.
Willis T. Diabetes: a medical odyssey. New York, Tuckahoe. 1971;197.
Diabetes SBd. Diretrizes da Sociedade Brasileira de Diabetes 2019-2020. São Paulo: Clannad; 2019. 491 p.
Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and Type 2 Diabetes Over the Lifespan: A meta-analysis. Diabetes Care. 1o de dezembro de 2008;31(12):2383–90.
Pan A, Lucas M, Sun Q, van Dam RM, Franco OH, Manson JE, et al. Bidirectional Association Between Depression and Type 2 Diabetes Mellitus in Women. Archives of Internal Medicine. 22 de novembro de 2010;170(21):1884–91.
Moulton CD, Pickup JC, Ismail K. The link between depression and diabetes: the search for shared mechanisms. The Lancet Diabetes & Endocrinology. 1o de junho de 2015;3(6):461–71.
Dirmaier J, Watzke B, Koch U, Schulz H, Lehnert H, Pieper L, et al. Diabetes in Primary Care: Prospective Associations between Depression, Nonadherence and Glycemic Control. PPS. 2010;79(3):172–8.
Zheng K, Abraham C, Bruzzese JM, Smaldone A. Longitudinal Relationships Between Depression and Chronic Illness in Adolescents: An Integrative Review. J Pediatr Health Care. agosto de 2020;34(4):333–45.
American Diabetes Association. 5. Lifestyle Management: Standards of Medical Care in Diabetes—2019. Diabetes Care. 7 de dezembro de 2018;42(Supplement_1):S46–60.
Herder C, Hermanns N. Subclinical inflammation and depressive symptoms in patients with type 1 and type 2 diabetes. Semin Immunopathol. julho de 2019;41(4):477–89.
Champaneri S, Wand GS, Malhotra SS, Casagrande SS, Golden SH. Biological Basis of Depression in Adults with Diabetes. Curr Diab Rep. 1o de dezembro de 2010;10(6):396– 405.
Bădescu S, Tătaru C, Kobylinska L, Georgescu E, Zahiu D, Zăgrean A, et al. The association between Diabetes mellitus and Depression. J Med Life. 2016;9(2):120–5.
Laake JPS, Stahl D, Amiel SA, Petrak F, Sherwood RA, Pickup JC, et al. The Association Between Depressive Symptoms and Systemic Inflammation in People With Type 2 Diabetes: Findings From the South London Diabetes Study. Diabetes Care. 12 de julho de 2014;37(8):2186–92.
Varshney P, Parveen R, Khan MA, Kohli S, Agarwal NB. Increased serum interleukin-9 and interleukin-1β are associated with depression in type 2 diabetes patients. Arq Neuro-Psiquiatr. 1o de junho de 2020;78:255–61.
Liu D, McIntyre RS, Li R, Yang M, Xue Y, Cao B. Genetic association between major depressive disorder and type 2 diabetes mellitus: Shared pathways and protein networks. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 20 de dezembro de 2021;111:110339.
Ji HF, Zhuang QS, Shen L. Genetic overlap between type 2 diabetes and major depressive disorder identified by bioinformatics analysis. Oncotarget. 19 de março de 2016;7(14):17410–4.
BMJ Publishing Group Ltd RC of P and BPS. Bidirectional association between elevated depressive symptoms and type 2 diabetes. Evidence-Based Mental Health. 1 o de fevereiro de 2009;12(1):24–24.
Ferreira MC, Piaia C, Cadore AC, Antoniolli MA, Gamborgi GP, Oliveira PP de. Clinical variables associated with depression in patients with type 2 diabetes. Rev Assoc Med Bras. agosto de 2015;61:336–40.
Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 1o de dezembro de 2010;53(12):2480–6.
Graham EA, Deschênes SS, Khalil MN, Danna S, Filion KB, Schmitz N. Measures of depression and risk of type 2 diabetes: A systematic review and meta-analysis. J Affect Disord. 15 de março de 2020;265:224–32.
Safren SA, Gonzalez JS, Wexler DJ, Psaros C, Delahanty LM, Blashill AJ, et al. A Randomized Controlled Trial of Cognitive Behavioral Therapy for Adherence and Depression (CBT-AD) in Patients With Uncontrolled Type 2 Diabetes. Diabetes Care. março de 2014;37(3):625–33.
Schmitt A, Reimer A, Ehrmann D, Kulzer B, Haak T, Hermanns N. Reduction of depressive symptoms predicts improved glycaemic control: Secondary results from the DIAMOS study. Journal of Diabetes and its Complications. 1o de novembro de 2017;31(11):1608–13.
Van der Feltz-Cornelis C, Allen SF, Holt RIG, Roberts R, Nouwen A, Sartorius N. Treatment for comorbid depressive disorder or subthreshold depression in diabetes mellitus: Systematic review and meta-analysis. Brain Behav. fevereiro de 2021;11(2):e01981.
Chen HM, Yang YH, Chen KJ, Lee Y, McIntyre RS, Lu ML, et al. Antidepressants Reduced Risk of Mortality in Patients With Diabetes Mellitus: A Population-Based Cohort Study in Taiwan. The Journal of Clinical Endocrinology & Metabolism. 1o de outubro de 2019;104(10):4619–25.
Wu CS, Hsu LY, Pan YJ, Wang SH. Associations Between Antidepressant Use and Advanced Diabetes Outcomes in Patients with Depression and Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism. 1o de dezembro de 2021;106(12):e5136–46.
Yekta Z, Xie D, Bogner HR, Weber DR, Zhang X, Harhay M, et al. The association of antidepressant medications and diabetic retinopathy among people with diabetes. Journal of Diabetes and its Complications. 1o de novembro de 2015;29(8):1077–84.
Gülseren L, Gülseren S, Hekimsoy Z, Mete L. Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients. Arch Med Res. abril de 2005;36(2):159–65.
Roopan S, Larsen ER. Use of antidepressants in patients with depression and comorbid diabetes mellitus: a systematic review. Acta Neuropsychiatrica. junho de 2017;29(3):127– 39.
Van der Feltz-Cornelis CM, Nuyen J, Stoop C, Chan J, Jacobson AM, Katon W, et al. Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. General Hospital Psychiatry. julho de 2010;32(4):380–95.
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Alex Moreira Souza, Jaydes Schultz Fuly, Bruna Livramento Barboza , Eduarda Nathália Dimas de Almeida , Eloisa Martins Clemente, Enzo Groff Romio , Glenda Ribeiro de Matos Emiliano , Idelândia Lacerda de Carvalho , Júlia de Queiroz Santos , Julia Tabile Casanova, Kássia Hellen Backes , Leonardo Dias Cézar , Michely Augusta do Nascimento, Pedro Henrique Moura Teixeira, Rosany Giavarotti de Carvalho, Vitória Teixeira Toniolli